Our research is the first to show that, although all three transcripts of the CDKN2A gene can suppress the growth of lung cancer cells with an inactivated CDKN2A locus, they have different effects, with the growth inhibitory effect of p16INK4a being the strongest. The gene discussed is CDKN2A; the disease is lung carcinoma.